Barbara Lopez Kunz, CEO of the Drug Information Association (DIA) in the USA, outlines the association’s four key areas of focus – regulatory science, patient engagement, translational science, and value and access – and highlights how it works with stakeholders across the healthcare continuum and across the globe.
Across the healthcare continuum, there really is no other neutral, global, interdisciplinary organization that covers the breadth of science, technology, and policy – whether it is drugs, devices, diagnostics, or digital – across the entire world, like we do
